NoDerog/iStock Unreleased via Getty Images Introduction Constellation Brands, Inc. ( STZ ) has been quite the laggard in terms of share price and even operations due to the shifting consumer tastes and overall tariff headwinds. I wanted to go over its performance and give some comments on its outlook and why I think it is still not a good time to start a position. Last time I covered the company w...
NoDerog/iStock Unreleased via Getty Images Introduction Constellation Brands, Inc. ( STZ ) has been quite the laggard in terms of share price and even operations due to the shifting consumer tastes and overall tariff headwinds. I wanted to go over its performance and give some comments on its outlook and why I think it is still not a good time to start a position. Last time I covered the company was back in June of last year , and since then, the company’s share price has been down almost 3%, while the broader market index is up 12%. Briefly on Performance Looking at the company’s revenue trend, we can see these have been declining for the whole year now. Some of this decline is due to the STZ’s strategically significant divestitures. The company has divested a big portion of its mainstream, lower-priced wines and spirits. Another reason the company’s top line has been on a decline is the fact that its beer segment began to see some headwinds after being a powerhouse for many years. High-end buy rates among the Hispanic consumers, who are STZ’s core demographic, declined more sharply than the general market due to macroeconomic pressures. Additionally, the rising costs of raw materials, like aluminum for cans, meant that the company had to increase prices, which tested consumer elasticity, leading to lower sales. Also, in broader terms, the younger generations are generally consuming less alcohol and opting for dry months and some other non-alcoholic alternatives, while the company’s premiumization strategy of selling more expensive drinks may be bad at this point due to persistent inflation, which is leading a lot of consumers to look for deals on cheaper brands. Seeking Alpha Going over to the company’s profitability and efficiency, we can see that over the last year, the margins across the board have been somewhat resilient. I was expecting to see steeper declines than what actually occurred, which tells us that the strategy of going towards more premium offering...
If you're looking for the company-specific headline that sent shares of Viking Therapeutics (NASDAQ: VKTX) soaring today, don't bother. You won't find one. Rather, investors are proverbially connecting dots based on other pharmaceutical companies ' headlines. In this instance, what's bad for (much-bigger) Novo Nordisk (NYSE: NVO) is good for Viking. Getting straight to the point, Novo Nordisk's in...
If you're looking for the company-specific headline that sent shares of Viking Therapeutics (NASDAQ: VKTX) soaring today, don't bother. You won't find one. Rather, investors are proverbially connecting dots based on other pharmaceutical companies ' headlines. In this instance, what's bad for (much-bigger) Novo Nordisk (NYSE: NVO) is good for Viking. Getting straight to the point, Novo Nordisk's injectable weight-loss drug CagriSema is good, but not better than Eli Lilly 's (NYSE: LLY) tirzepatide when administered the same way for the same length of time. Specifically, whereas patients receiving subcutaneous injections of Lilly's tirzepatide lost an average of 25.5% of their body weight over 84 weeks, CagriSema users only lost an average of 23%. To win the FDA's approval, a new treatment must be at least as effective as an alternative that's already on the market, or offer some other discernible benefit like better patient tolerability. Continue reading
Eversource Energy is set to raise $1.5 billion from selling its first hybrid bonds, as the New England utility operator looks to refinance debt. The 30.5-year securities are being offered in two $750 million parts, according to a person with knowledge of the matter. One of the bonds can’t be bought back for 5.25 years, and the other not for 10.5 years, said the person, who asked not to be identifi...
Eversource Energy is set to raise $1.5 billion from selling its first hybrid bonds, as the New England utility operator looks to refinance debt. The 30.5-year securities are being offered in two $750 million parts, according to a person with knowledge of the matter. One of the bonds can’t be bought back for 5.25 years, and the other not for 10.5 years, said the person, who asked not to be identified as they’re not authorized to speak publicly. The notes are poised to respectively yield 6.1% and 6.35%, both about 0.4 percentage point less than initial price talk, the person added. Hybrid bonds have features of both debt and equity. They’ve grown more popular in recent years, particularly among utility holding companies , after a change in policies from Moody’s Ratings made it easier for corporations to determine how much equity-like credit they would get for selling the securities. Barclays Plc, Bank of America Corp., Citigroup Inc., JPMorgan Chase & Co., Morgan Stanley and Mitsubishi UFJ Financial Group Inc. are bookrunners for the debt sale. The deal is among 10 in the US investment-grade market on Monday — half of them from utilities.
Former British ambassador to the US Peter Mandelson has been arrested by London police on suspicion of misconduct in public office, following revelations over his ties to convicted sex offender Jeffrey Epstein. Mandelson, 72, was fired from the most prestigious posting in Britain’s diplomatic service in September, when the depth of his friendship with Epstein started to become clear. Police earl...
Former British ambassador to the US Peter Mandelson has been arrested by London police on suspicion of misconduct in public office, following revelations over his ties to convicted sex offender Jeffrey Epstein. Mandelson, 72, was fired from the most prestigious posting in Britain’s diplomatic service in September, when the depth of his friendship with Epstein started to become clear. Police earlier this month began a criminal investigation into Mandelson after Prime Minister Keir Starmer’s...
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
In trading on Monday, shares of EOS Energy Enterprises Inc (Symbol: EOSE) crossed below their 200 day moving average of $10.19, changing hands as low as $10.01 per share. EOS Energy Enterprises Inc shares are currently trading down about 5.3% on the day. The chart below shows
In trading on Monday, shares of EOS Energy Enterprises Inc (Symbol: EOSE) crossed below their 200 day moving average of $10.19, changing hands as low as $10.01 per share. EOS Energy Enterprises Inc shares are currently trading down about 5.3% on the day. The chart below shows
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
Shares of cancer immunotherapy specialist ImmunityBio (NASDAQ: IBRX) are up 16% as of noon ET on Monday after the company reported fourth-quarter earnings. The company's leading immunotherapy (and main sales generator), Anktiva, grew sales by 700% in 2025, and delivered 20% quarter-over-quarter growth in Q4. While earnings per share remained negative at $0.06 in Q4, it was the third straight quart...
Shares of cancer immunotherapy specialist ImmunityBio (NASDAQ: IBRX) are up 16% as of noon ET on Monday after the company reported fourth-quarter earnings. The company's leading immunotherapy (and main sales generator), Anktiva, grew sales by 700% in 2025, and delivered 20% quarter-over-quarter growth in Q4. While earnings per share remained negative at $0.06 in Q4, it was the third straight quarter of profitability improvement as Anktiva rapidly expands. Following today's rise on ImmunityBio's solid earnings, the stock has already roughly quintupled in 2026 as it continues to reel off positive news. Through its Cancer BioShield platform and Anktiva biologic product, ImmunityBio stimulates natural killer cells, cytotoxic T cells, and memory T cells, helping patients fight a growing number of cancers and diseases. While the bulk of ImmunityBio's business currently comes from U.S. sales of Anktiva, a treatment for bladder cancer cases that did not respond to the Bacille Calmette-Guérin (BCG) vaccine, the company is rapidly expanding. Image source: Getty Images. Continue reading
Novo Nordisk’s next-generation obesity shot delivered less weight loss than Eli Lilly rival blockbuster in yet another blow to the Danish company’s attempts to regain lost ground in the weight-loss market. People treated with a standard dose of Novo’s CagriSema in a trial achieved 20.2% weight loss after 84 weeks, compared with 23.6% for Lilly’s tirzepatide. Sam Fazeli of Bloomberg Intelligence jo...
Novo Nordisk’s next-generation obesity shot delivered less weight loss than Eli Lilly rival blockbuster in yet another blow to the Danish company’s attempts to regain lost ground in the weight-loss market. People treated with a standard dose of Novo’s CagriSema in a trial achieved 20.2% weight loss after 84 weeks, compared with 23.6% for Lilly’s tirzepatide. Sam Fazeli of Bloomberg Intelligence joins to discuss. He also breaks down how Merck is splitting its main pharmaceutical unit in two in an effort to better highlight the parts of the business that are growing, as it stares down a patent cliff for its best-selling cancer drug Keytruda. (Source: Bloomberg)
In trading on Monday, the iShares U.S. Pharmaceuticals ETF is outperforming other ETFs, up about 1.1% on the day. Components of that ETF showing particular strength include shares of Eyepoint, up about 5.4% and shares of Ocular Therapeutix, up about 5% on the day. And underper
In trading on Monday, the iShares U.S. Pharmaceuticals ETF is outperforming other ETFs, up about 1.1% on the day. Components of that ETF showing particular strength include shares of Eyepoint, up about 5.4% and shares of Ocular Therapeutix, up about 5% on the day. And underper
Exchange Income Corp. , which acquires and operates aerospace, aviation and manufacturing businesses, is preparing to sell as much as C$500 million ($365 million) of bonds in its first note sale, according to people familiar with the matter. The Winnipeg, Canada-based firm is looking at debt that matures in five or seven years, the size of the deal could range from C$300 million to C$500 million, ...
Exchange Income Corp. , which acquires and operates aerospace, aviation and manufacturing businesses, is preparing to sell as much as C$500 million ($365 million) of bonds in its first note sale, according to people familiar with the matter. The Winnipeg, Canada-based firm is looking at debt that matures in five or seven years, the size of the deal could range from C$300 million to C$500 million, said the people, who asked not to be identified as they aren’t authorized to speak publicly. The firm received a BBB (low) issuer rating with a stable trend from Morningstar DBRS last week. The lowest investment grade rating reflects its “well-established lines of services, albeit limited to niche markets,” according to DBRS analysts. Exchange Income Corp.’s businesses provide services and goods ranging from air ambulance to defense sector components. Executives are due to speak with investors on Wednesday, Bloomberg reported last week. A bond sale could come as soon as this week, the people said. Representatives did not immediately respond to a request for comment.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me
In trading on Monday, apparel stores shares were relative laggards, down on the day by about 5.5%. Helping drag down the group were shares of Stitch Fix, off about 9.2% and shares of American Eagle Outfitters off about 9% on the day. Also lagging the market Monday are textiles
In trading on Monday, apparel stores shares were relative laggards, down on the day by about 5.5%. Helping drag down the group were shares of Stitch Fix, off about 9.2% and shares of American Eagle Outfitters off about 9% on the day. Also lagging the market Monday are textiles
asbe/iStock via Getty Images By Ezequiel Gomes Silver ( XAGUSD:CUR ) pushed sharply higher this Monday as traders tracked a fresh surge in haven demand tied to rising U.S.-Iran tensions and new uncertainty around U.S. trade policy. This mix also kept currency markets jumpy and amplified moves across precious metals. Market snapshot Silver was last around $87.28, extending a powerful rebound that h...
asbe/iStock via Getty Images By Ezequiel Gomes Silver ( XAGUSD:CUR ) pushed sharply higher this Monday as traders tracked a fresh surge in haven demand tied to rising U.S.-Iran tensions and new uncertainty around U.S. trade policy. This mix also kept currency markets jumpy and amplified moves across precious metals. Market snapshot Silver was last around $87.28, extending a powerful rebound that has been defined by wide daily ranges rather than steady step-by-step gains. The day’s range mattered as much as the level. Trading data showed silver moving between about $84.39 and $87.87, a band that underscores how quickly liquidity and sentiment have been flipping in late-February trade. Silver price dynamics (January - February 2026) (Source: TradingView) In the broader complex, precious metals moved higher together, with silver outperforming as investors leaned into protection trades and shorter-term momentum strategies. Drivers traders cited: risk headlines, tariffs, and FX Geopolitical risk remained a primary catalyst. Markets kept a close watch on developments tied to U.S.-Iran tensions, which have periodically lifted demand for defensive assets and widened price reactions in metals. Trade policy uncertainty added a second layer. A U.S. Supreme Court ruling on tariffs, followed by renewed tariff announcements and legal questions, fed a “policy risk premium” that helped support havens and kept cross-asset correlations unusually tight. Foreign exchange moves also mattered because silver is dollar-priced. The dollar’s response to the court decision and subsequent headlines shaped how aggressively non-U.S. buyers and macro funds were willing to add exposure into strength. What comes next: Rates calendar and key levels Even with geopolitics in the driver’s seat, traders still treated rates as the gatekeeper for durability. If yields stay firm, rallies can struggle to hold; if yields ease, silver tends to keep more of its gains after the initial headline impulse. This we...